Cardiopulmonary Failure and Transplant Program

The Cardiopulmonary Failure and Transplant Program is a joint effort of The Heart Center and Pulmonary Medicine and was built on a commitment to comprehensive resources and compassionate care.

With the extensive clinical, diagnostic and surgical capabilities of The Heart Center as its foundation, we are equipped and staffed to address all aspects of heart failure and transplant care, including lung and heart-lung transplant services.

Under the leadership of Timothy Hoffman, MD, Medical Director of the Heart Failure and Heart Transplant Program; Don Hayes, MD, Medical Director of the Lung and Heart-Lung Transplant Program, and Mark Galantowicz, MD, Program Surgical Director, Nationwide Children’s Hospital has received widespread recognition for its innovation and leadership on a national level.

Expertise in these areas of Cardiopulmonary Failure and Transplant

• Heart-failure management in the critical care setting
• Transplant care for the medically high-risk recipient
• Mechanical circulatory assist
• Multi-center research
• Quality and safety

Cardiopulmonary Failure and Transplant Program Results

30-Day Survival

• Pediatric: 96 percent (Expected national average: 95 percent)
• Adult: 100 percent (Expected national average: 87 percent)

One-Year Survival

• Pediatric: 87 percent (Expected national average: 88 percent)
• Adult: 100 percent (Expected national average: 77 percent)